IL-2 has been shown to activate T cells, which can then target and kill cancer cells, while IL-2R is expressed on the surface of certain immune cells, such as natural killer (NK) cells, and can help to stimulate these cells to fight cancer [12, 13]. This evidence concerns the gene IL2 and cancer.